This review addresses the scope of influence of mRNA decay on cellular functions and its potential role in normal and malignant hematopoiesis. Evidence is emerging that leukemic oncogenes and hematopoietic cytokines interact with mRNA decay pathways. These pathways can co-regulate functionally related genes through specific motifs in the 3 0 -untranslated region of targeted transcripts. The steps that link external stimuli to transcript turnover are not fully understood, but include subcellular relocalization or post-transcriptional modification of specific transcript-stabilizing or -destabilizing proteins. Improper functioning of these regulators of mRNA turnover can impede normal cellular differentiation or promote cancers. By delineating how subsets of transcripts decay in synchrony during normal hematopoiesis, it may be possible to determine whether this post-transcriptional regulatory pathway is hijacked in leukemogenesis.
Introduction
This review addresses the scope of influence of mRNA decay on cellular functions and its potential role in normal and malignant hematopoiesis. The impetus for this review is a growing body of knowledge that implicates the pathways and proteins involved in mRNA turnover in shifts in the expression of functionally related genes. As a result of these shifts in the transcriptional repetoire, the trajectory of cellular fates can be reoriented possibly leading to differentiation or to malignancy.
It has long been appreciated that coordinated changes in gene expression are central to the transition from hematopoietic progenitors to committed unilineage and terminally differentiated cells. A number of transcription factors that serve as master switches in the execution of lineage-specific transcriptional programs have been identified (for review, see Calabretta and Skorski 1 ). Leukemogenesis has been associated with aberrant activation or suppression of many of these regulatory transcription factors, including AML-1, SCL, MLL, Gfi-1, ELKF, Gata1, HoxA9, C/EBPa, RAR. [2] [3] [4] [5] Several approaches, including microarray studies, conditional knock-ins and chromatin immunoprecipitation analyses have demonstrated that key hematopoietic transcription factors co-regulate genes in pathways that affect cell phenotypes.
The post-transcriptional coordination of functionally related genes has been less well documented. RNA processing, nuclear export, RNA turnover and translation are all subject to regulation and have the potential to facilitate rapid changes in steady-state levels of transcripts and their products. Interest in the control of RNA translation has been spurred by the recent discovery of 22-bp microRNAs, each with the potential to suppress translation of dozens of genes. Changes in microRNA expression profiles have been implicated both in development and in carcinogenesis (reviewed by Kloosterman and Plasterk 6 ). The involvement of microRNAs in leukemogenesis has recently been reviewed in Leukemia 7 and will not be discussed below. A number of studies have highlighted the importance of mRNA translational control in promyelocyte differentiation and in leukemic transformation. The Bcr-Abl oncoprotein has been shown to augment the translation of mRNA coding for the p53-antagonist mdm2 8 or for c-myc 9 and to inhibit the translation of the C/EBPa gene that promotes myeloid differentiation. 10 It mediates these effects by enhancing the level of the RNA binding proteins (RNABPs) La, hnRNP K and hnRNP E2 that bind to mdm2, myc and C/EBPa transcripts, respectively. Translational control by Bcr-Abl has been reviewed by Perrotti and Calabretta. 11 The myeloid leukemia fusion proteins AML1-MDS1-EVI1 and CBFB-SMMHC also inhibit C/EBPa translation. They upregulate the expression of the RNABP calreticulin 12, 13 that binds to the C/EBPa transcript to impede translation. 14 Changes in the stability of mRNA also can dramatically affect cell function. Coordinate stabilization (or destabilization) of transcripts is highly ordered and is dependent on regulatory sequences (generally in the mRNA 3 0 -untranslated region, hereafter 3 0 -UTR) that bind to a common set of RNABPs. These regulatory sequences may be shared between transcripts and couple their turnover. Such dynamic post-transcriptional regulation has been functionally compared with prokaryotic operons linking genes in signaling pathways. 15 Indeed, the 3 0 -UTR has been deemed a 'hotspot' for pathology. 16 The pathways that mediate coordinate regulation of RNA turnover are just beginning to be understood, as are the rules governing which transcripts are stabilized or destabilized in response to external stimuli. Accumulating evidence indicates that cytokines function in part by controlling transcript stability. We will review the evidence for coordinated transcript turnover, the mechanisms through which it occurs, and whether this function could be appropriated by leukemic oncoproteins to sustain cell survival and prevent differentiation.
Control of mRNA stability
Many RNA transcripts turn over rapidly -these generally encode inducible proteins whose levels change rapidly in response to extracellular stimuli. The short half-lives of these RNAs means that a burst of transcription can dramatically alter the steady-state mRNA level. If a transcript's half-life is lengthened concurrently with increased transcription, the steady-state level of mRNA is further increased. Coincident increases (or decreases) in transcription and in stability therefore magnify signals. On the other hand, stabilization and transcription can be discordant. In such cases, ongoing transcription does not lead to protein expression because of mRNA degradation. External signals that stabilize a subset of transcribed genes can augment the levels of those transcripts without affecting co-transcribed genes. Regulation of mRNA stability thereby exerts an additional level of control over gene expression.
The stability of mRNA is determined by cis-elements within transcripts as well as by trans-acting factors that bind to them. The 5 0 -terminal cap (7GpppN) and the 3 0 -terminal polyA tail sustain mRNA integrity. The polyA tail is bound by polyA binding proteins that require at least 27-bp of polyA to bind and stabilize the transcript. Degradation of mRNAs begins with 3 0 -5 0 deadenylation, followed by 3 0 -5 0 exonucleolytic degradation or cap removal and 5 0 -3 0 exonucleolytic decay. Decapping can also occur independently of deadenylation.
17 mRNAs can also be degraded by endonuclease digestion. The latter decay mechanism may be prevented by protection of the cleavage site by RNABP. 18 Several sequence elements within transcripts have been linked to the control of mRNA turnover. Most prominently, AU-rich elements (ARE) in 3 0 -UTR characterize most short-lived transcripts. Roughly 4000 genes are known to contain these elements. 19 Destabilizing RNABPs have been shown to direct ARE-containing mRNA to the exosome, a multisubunit protein complex containing exonucleases that degrade mRNA. [20] [21] [22] Conversely, RNA can be stabilized by proteins that compete for ARE binding and direct transcripts to the polysome for translation.
Regulatory elements in 3
0 -UTR of transcripts
Twenty years ago, AU-rich motifs were identified in the 3 0 -UTRs of multiple inflammatory mediators, including tumor necrosis factor, lymphotoxin, colony-stimulating factor and IL-1. 23 The transfer of one such ARE sequence from granulocyte macrophage colony-stimulating factor (GM-CSF) resulted in instability of a linked b-globin transcript. 24 Subsequently, multiple immediate response genes, cell-cycle genes, transcription factors or oncogenes were found to encode short-lived transcripts containing ARE sequences (reviewed by Bevilacqua et al.
25
). These motifs facilitate the rapid turnover of these transcripts and help to prevent inappropriate accumulation of the regulatory molecules that they encode. The physiologic significance of ARE-mediated turnover is manifest in mice transgenic for a GM-CSF gene lacking ARE sequences. These mice overproduced granulocytes and macrophages and died in utero. 26 Transgenic mice lacking the ARE sequence in the TNFa gene similarly developed inflammatory diseases. 27 Chen and Shyu 28, 29 have conducted a functional analysis of AU-rich sequences. They described three classes of AREs: class 1, present in immediate response genes (e.g. c-myc, c-fos and cyclin D1) bearing scattered repeats of the sequence AUUUA; class 2 AU-rich sequences present in cytokine genes (e.g. GM-CSF, TNFa) that have multiple iterations of the AUUUA motif; a class 3 U-rich class (e.g. c-jun) lacking AUUUA motifs was subsequently described. Single AUUUA motifs are not necessarily sufficient to trigger degradation, and mutagenesis studies of single or multimeric AU-rich motifs have sought to determine minimal sequences that suffice to destabilize RNA [30] [31] [32] Further investigations, however, have shown that the ability of sequence motifs to destabilize transcripts in trans can vary depending on the fused transcript or the cell type studied. 33, 34 This underscores the complex nature of mRNA turnover control and possibly the different repetoires of RNABP available in different cells. Selectivity also arises because different AU-rich sequences appear to be targeted by distinct RNABPs (e.g. Park-Lee et al.
35
). AU-rich motifs that are targeted by specific RNABPs have been identified through immunoprecipitation of that protein and comparison of bound mRNA sequences. 36 Consensus binding sites for regulatory RNABPs have also been defined by SELEX selection. 37 In some transcripts, noncontiguous motifs are necessary to convey transcript instability. For example, elements within the interleukin (IL)-2 coding region or the CXCL1 5 0 -UTR are required in addition to ARE sequences in the 3 0 -UTR to control transcript turnover. [38] [39] A hairpin loop in the IL-6 3 0 -UTR is needed in addition to the ARE for full destabilization. 40 In addition to AREs, other sequence determinants include poly-C tracts -these have been shown to contribute to a-globin transcript stability. 41 Darnell's laboratory has examined global transcript decay rates in HepG2 and Bud8 cells exposed to the transcriptional inhibitor actinomycin D and identified multiple sequence elements that were statistically linked to rapid transcript turnover. 42 However, most of these sequences have not undergone functional testing.
The 3 0 -UTR is a composite structure of multiple regulatory elements that may respond in a coordinated fashion to a single stimulus, 43 or might each respond to a different stimulus. The 3 0 -UTR of the p21 gene, for instance, contains an ARE that promotes p21 turnover but is bound by stabilizing proteins to increase p21 mRNA half-life in response to a-1 agonists, 44 prostaglandin A1, 45 ultraviolet light 46 and mediators of muscle 47 or neuronal differentiation. 48 Epidermal growth factor-mediated stabilization of p21 49 occurs via a downstream element in the 3 0 -UTR. Additional sequence elements in the 3 0 -UTR mediate translational control of the p21 transcript. 48 RNA folds into complex structures including stems, loops and bulges. 50 Although stabilizing RNABPs display a high affinity for consensus sequences, 37, 51, 52 binding is also controlled by structural determinants. 53 Fialcowitz 54 has recently demonstrated that the ARE of the TNFa transcript can assume a hairpin structure to which a stabilizing (HuR) protein can bind but a destabilizing protein (AUF1p37) that recognizes the unfolded sequence can no longer bind. Whether external stimuli or flanking sequences prompt motifs to assume higher-order structures that differ in their affinity for binding proteins is unknown. The mRNA conformational requirements for protein binding have been exploited by Meisner et al., 51 who have devised a methodology to artificially open or close the accessibility of binding motifs in 3 0 -UTRs.
Trans-regulators of mRNA turnover
The processing and metabolism of mRNA is choreographed by hundreds of proteins. 55, 56 Only a handful of these have been validated as regulators of mRNA turnover. This section will focus on RNABPs that bind to ARE sequences, with a particular focus on those whose targets, regulation and mechanism of action have been best characterized -the stabilizing protein HuR and the AUF1 protein that is primarily (but not exclusively) linked to destabilization.
Stabilizing proteins
The primary mRNA stabilizing proteins that have been studied are the Hu proteins -these include HuB, C, and D in neurons and HuR that is ubiquitously expressed. These proteins recognize ARE sequences. 57, 58 Hu proteins contain two RNA recognition motifs (RRMs) that bind U-rich sequences followed by a spacer that controls its subcellular localization and then a third RRM that binds to the polyA tail. Conceivably, HuR could tether the polyA tail to the body of the transcript to inhibit deadenylation. Using confocal fluorescence fluctuation analysis, Meisner et al. 51 demonstrated that the sequence NNUUN-NUUU was the minimal recognition sequence for HuR in 54 experimentally confirmed HuR-bound transcripts. It was noted that the affinity of HuR for RNAs containing this sequence varied by 100-fold, and that HuR binding affinity increased with the likelihood that the recognition site was presented in a singlestranded conformation. Conceivably, flanking sequences and adjacent binding proteins affect mRNA folding so that the affinity of a transcript to HuR could change in a dynamic fashion. HuR therefore recognizes a subset of AREs rather than binding promiscuously. The heterogeneity of ARE sequences stabilized by HuR offers an additional layer of control in coordinating cellular responses to stimuli that affect mRNA decay. 60 The accessibility of HuR to mRNA is controlled by shifts in the subcellular localization of HuR. In response to cytokines, hormones, ATP depletion, differentiation stimuli or heat shock, HuR shuttles from the nucleus to the cytoplasm. 47, [61] [62] [63] [64] This involves the binding to HuR of one of several protein partners that couple HuR to the CRM1 nuclear export pathway. 65, 66 PKCa stabilizes neuronal transcripts by inducing redistribution of Hu proteins from the nucleus to the cytoskeleton. 67 Although AMP-activated protein kinase (AMPK) has also been shown to cause nuclear export of HuR, 68 direct phosphorylation of HuR has not been shown. Nonetheless, HuR phosphorylation may be necessary for its function -binding of cytoplasmic HuR to p21 transcript has been shown to be Erk-dependent. 45 HuR has been shown to be a substrate for the CARM1 methylase in LPSexposed cells, indicating that HuR activity may also be controlled by methylation. 69 Protein-protein interactions can also affect Hu protein function. The hnRNPK protein has been shown to bind HuD and prevent it from stabilizing p21. 48 HuR stabilizes transcripts in response to many stimuli, including ultraviolet radiation, hypoxia, inflammatory stimuli and serum stimulation of resting cells. 46, [70] [71] [72] [73] HuR expression and mRNA binding activity decreases during senescence, concurrent with destabilization of c-fos and cyclin mRNAs. 74 HuR is generally thought to stabilize transcripts by preventing the binding of destabilizing proteins to the ARE Such a competition model is compatible with the overlapping tissue distribution of HuR and the destabilizing protein AUF1. 75 Lal et al. 76 showed that the majority of HuR bound transcripts could also bind AUF1 and vice versa. A direct competition between HuR and AUF1 has been shown to modulate stability of the p21, ATF3 and cyclin D1 transcripts. 76, 77 Investigation of HuR stabilization of the p21 transcript indicates that in some cases transcripts can be bound concurrently by HuR and Auf and that either can then displace the other depending on their relative abundance. 76 HuR-mediated mRNA stabilization reinforces signaling pathways known to be important in leukemias. The Wnt pathway sustains self-renewal of hematopoietic stem cells and aberrant Wnt activation contributes to lymphoid and myeloid malignancies. [78] [79] [80] An interesting cascade involving HuR stabilization of transcripts has recently been reported in pituitary cells following Wnt-pathway activation. 81 Briata et al. 81 demonstrated that HuR competes with the destabilizing proteins KSRP and tristetraprolin (TTP) in controlling the stability of Pitx2, a Wnt-induced transcription factor essential for normal development. HuR bound the ARE of Pitx2 to stabilize its transcript. The Pitx2 protein subsequently formed a complex with HuR that bound the ARE and stabilized the transcripts for proliferative genes including cyclin D1, cyclin D2 and c-myc. HuR also competes with KSRP to stabilize the mRNA of b-catenin, a downstream effector of Wnt signaling. 82, 83 It was recently reported that b-catenin also forms a complex with HuR to stabilize the transcript for cyclooxygenase-2 (Cox-2) through its ARE. 84 These observations, summarized in Figure 1 , underscore a central role for HuR in sustaining cascades of mRNA stabilization that support Wnt function. They also may explain why overexpression of Hu proteins are associated with poor outcomes in several cancers. 82, [85] [86] [87] [88] The central role of HuR in coordinating post-transcriptional aspects of Wnt signaling also support a role for Hu proteins in stem cell development. 89 The Hu proteins are not the only RNABPs that have been shown to stabilize mRNA. Other proteins implicated in RNA stabilization include RNPC1, 90 the poly (C)-binding protein aCP1, 91 and the ARE-binding proteins NF90, 92, 93 and nucleolin. [94] [95] [96] [97] The aCP-binding proteins are important in stabilizing aglobin mRNA and have been reviewed elsewhere. 98 Nucleolin has been investigated extensively for its roles in transcription, splicing and nucleolar function (reviewed by Ginisty et al.
99
) but only a handful of papers have examined it as a regulator of mRNA turnover. NF-90 has been well studied as a transcription factor binding to the IL-2 enhancer, but has also been found to be exported from the nucleus in activated T cells and to stabilize IL-2 transcripts via their ARE. 93 In addition to these factors, several reports suggest that AUF1 can have a stabilizing as well as a destabilizing function, depending on the transcript, cell and conditions under study.
Interestingly, HuR may in some cases act to build up stores of untranslated mRNAs. In myeloid cells, HuR has been demonstrated not only to stabilize TNFa mRNA, but also (through interactions with the TIA-1 protein) to prevent TNFa translation. 59 As a result, HuR can act to limit inflammation. It is likely that HuR helps to direct certain target transcripts to stress granules that are repositories of untranslated RNAs, which are subsequently sorted for translation or degradation. 100, 101 This additional level of control fine-tunes the kinetics of posttranscriptional cytokine production.
Destabilizing proteins
Destabilization of RNA has been attributed in most cases to binding by the AUF1 protein (particularly its p37 isoform) or to binding by TTP, BRF1 or KSRP protein. How these proteins initiate RNA decay has not been fully worked out; KSRP has been shown to interact with the exosome in a phosphorylationdependent manner 83 and to recruit polyA ribonuclease (PARN) to mRNA transcripts to initiate exosome binding and deadenylation. 22 TTP and BRF1 also stimulate PARN activity, suggesting that this could be a general phenomenon. 102, 103 Interestingly, TTP degradation of the TNFa transcript was shown to require microRNA production and involved a complex of a microRNA complementary to the ARE sequence, TTP and components of the RNA-induced silencing complex involved in RNA interference. 104 This raises the intriguing possibility that destabilizing RNABPs might be sorted to their targets in part through the homing activity of microRNAs, and that RNA degradation recruits enzymatic functions involved in microRNA processing.
By far, the best-studied RNA destabilizing protein is AUF1 (hnRNP D). The physiologic importance of AUF1 is perhaps best illustrated by the occurrence of endotoxic shock in AUF1 knockout mice resulting from excessive buildup of proinflammatory cytokines that depend on AUF1 for their degradation.
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AUF1 also coordinates developmental differences in mRNA stability. For instance, the turnover rate of GM-CSF message in cord blood mononuclear cells is three times faster than in adult mononuclear cells because of increased AUF1 levels and activity. 106, 107 AUF1 may also choreograph different turnover rates of gene variants. A short-lived polymorphic variant of thymidylate synthase was shown preferentially to bind AUF1, leading to its decay.
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AUF1 was identified in Brewer's laboratory in 1991 based on its ability to bind and degrade c-myc mRNA in a cell-free system and was cloned 2 years later. 109, 110 AUF1 proteins contain two RNA recognition motifs and bind to their mRNA targets as dimers. 111 Sequential dimer binding causes local remodeling and condensation of the mRNA substrate. 112, 113 Through alternative splicing, AUF1 is expressed as 37, 40, 42 and 45 kDa isoforms 114 ( Figure 2 ). The p45 isoform contains 19 amino acids coded by exon 2 and 49 amino acids coded by exon 7; p42 contains exon 7; p40 contains exon 2 and p37 contains neither. Exon 7 contains sequences that inhibit ubiquitination and degradation of AUF1, therefore the p45 and p42 isoforms usually predominate over the ubiquitinated p40 and p37 forms. 115 There is some evidence that degradation of AUF1 targeted mRNAs is dependent on ubiquitinationinactivation of the E1 ubiquinating enzyme results in nuclear/ perinuclear sequestration of AUF1. 116, 117 The exact function of each of the AUF1 isoforms remains controversial. Isoform-specific knockdown experiments showed that transcripts were stabilized when only p40 and p45 were knocked down, implicating these in decay. 118 Transfection studies on the other hand have shown that the p37 and p40 isoforms were the major mediators of mRNA decay. 119 Although the p37 isoform is generally the least abundantly expressed, it has the strongest affinity for AREs in vitro.
114 Knockdown experiments targeting all four AUF1 isoforms have confirmed the destabilizing effects of AUF1 against multiple ARE-containing transcripts. 43, 108, [120] [121] [122] Although many reports demonstrate a destabilizing effect of AUF1 on mRNA transcripts, some studies indicated that it can also have a stabilizing effect. Overexpression of each of the four AUF1 isoforms stabilized a b-globin construct containing a GM-CSF or c-fos ARE. 34 In another study, overexpression of the p37 and p42 isoforms stabilized a construct bearing the IL-6 3 0 -UTR. However, knockdown of all four endogenous AUF1 isoforms in that same study also stabilized the construct. 40 Transgenic mice that overexpressed p37 exhibited increased expression of classes I and III ARE-containing transcripts, particularly in tissues with low levels of endogenous AUF1. 123 In contrast, the expression of the class II ARE transcripts TNFa and GM-CSF were decreased in p37 overexpressing tissues. These results suggest either that overexpression studies alter AUF1 complex formation or titrate a limiting decay-inducing factor, that auxiliary-binding proteins control AUF1 activity, or that the ratio of isoforms controls AUF1 destabilizing function.
AUF1 isoforms shuttle between the nucleus and cytoplasm. 124 When fused with a fluorescent reporter, the two larger isoforms contain a nuclear export signal, whereas the two smaller isoforms were shown to mediate nuclear import. 125 Recently, the 14-3-3sigma protein was shown to bind to the nuclear localization signal in the smaller isoforms, leading to their cytoplasmic accumulation and enhanced degradation of AREcontaining transcripts. 121 The physiologic triggers of AUF1 shuttling are largely unknown.
AUF1 is regulated by phosphorylation. Phorbol ester treatment of monocytic leukemic cells is associated with loss of 
126 Fluorescence resonance energy transfer (FRET) analysis demonstrated that the doubly phosphorylated AUF1 has lost its ability to remodel bound RNA. 113 A decrease in AUF1 phosphorylation by cyclosporine A has been observed, suggesting that calcineurin can modulate AUF1 activity through phosphorylation. 127 AUF1 has also been shown to be phosphorylated on tyrosines by the NPM-ALK oncoprotein, as discussed below. The physiologic significance of basal and regulated phosphorylation of AUF1 has yet to be fully explored. Conceivably, phosphorylation or other post-translational modifications could promote a switch of AUF1 from a destabilizing to a stabilizing activity at class I AREs such as c-myc or cyclin D1, causing an increase in cell proliferation. AUF1 modifications could conceivably act by altering its structure, dimer formation, target selection or association with auxiliary proteins. Such modifications could explain, for example, why AUF1 stabilizes IL-3 transcript in 3T3 cells and destabilizes it in K562 cells 128, 129 as cited by Bevilacqua et al. 25 
Networks of coordinately stabilized transcripts
Gene ontology analysis of ARE-containing transcripts indicates enrichment for two dozen functional categories, most notably for genes associated with cellular proliferation. These were five times more frequent in the ARE library than in the transcriptome at large. 19 The functional grouping of ARE-containing transcripts is congruent with findings that mRNAs in the same pathways could share similar decay kinetics 42 and may also share overlapping control mechanisms. It was recently demonstrated, for instance, that interferon gamma synchronously increased expression of proinflammatory molecules through a signaling pathway directed at AREs in their transcripts. 130 In human cells, several groups have conducted kinetic microarray analyses to monitor global shifts in the stability of transcripts in cells exposed to different stimuli. Frevel et al. 131 utilized a custom array of 950 AU-response element (ARE)-containing transcripts to demonstrate that a subset of transcripts in THP-1 monocytes were stabilized by lipopolysaccharide in a p38-dependent manner. Three other groups have used similar methodology to study transcript half-life. Raghavan et al. 132 used actinomycin D chase followed by Affymetrix arrays to identify T-lymphocyte transcripts whose mRNA stability was altered by T-cell activation, uncovering coordinate regulation of many proliferation or signaling pathway transcripts. This paralleled results from the study of Lam et al. 133 on lymphocytes, which demonstrated that flavopiridol-mediated destabilization preferentially of proliferative or cytokine genes that had high basal turnover rates. A similar approach was used by Darnell's laboratory, 42 who noted a correlation between transcript function and the decay rate in HepG2 cells and in Bud8 fibroblasts. Given that genes in specific pathways can respond to external stimuli with synchronized shifts in mRNA half-life, one could ask whether cellular transformation alters the turnover of linked transcripts. Vlasova 134 has compared the mRNA decay rates of 7000 transcripts in primary human T cells and in two malignant T cell lines. Of 2000 transcripts that were overexpressed in the cell lines, 100 were stabilized, and 17% of these mapped to the ubiquitin proteasome system in both cell lines.
In summary, these studies indicate that large subsets of cellular mRNA change their half-life in response to external stimuli, and that pathways hitherto investigated in transcriptional regulation (such as the p38 pathway) also serve as posttranscriptional regulatory pathways. What remains unclear are the exact mechanisms that couple the turnover of distinct transcripts. A simple model would be that transcripts are sorted into similar or different decay fates by RNABPs that are activated by the stimulus. An appealing notion is that functionally-related transcripts share a 3 0 -UTR 'zip code' that is used by those proteins to dictate the fate of the transcript. However, this is probably an oversimplification because transcripts may be coregulated in one setting and not another. Several factors could determine which subset of ARE-containing transcripts are stabilized or destabilized in tandom. These include not only the RNA sequence and structure, but also which RNABP(s) that could bind to the ARE are activated or translocated out of the nucleus. We discuss below the evidence for binding of regulatory proteins to functionally coherent sets of transcripts.
RNABPs and the sorting of the transcriptome
There is growing evidence that sequence-directed interactions of RNABPs with elements in the 3 0 -UTR contribute to the coordinate regulation of mRNA subpopulations. Some of the most elegant data linking specific RNABPs to gene subsets arises from yeast studies. In a yeast model of iron deficiency, the Cth2 RNABP stimulates degradation of multiple ARE-containing transcripts to reprogram metabolism. 135 Gerber et al. 52 has demonstrated that five distinct but related RNABPs (Puf1p-Puf5p) in yeast each bound to different functional classes of RNAs, and that selective binding was guided by different motifs in the targeted 3 0 -UTRs. For instance, of 154 transcripts that bound to Puf3p, 135 were associated with mitochondrial function. Similar selectivity was found for a Puf3p homologue in drosophila. 136 Strategies used in such studies involve isolation of RNABP-bound mRNAs through precipitation of RNABPs from extracts of polysomes or whole cells, an approach termed 'Ribonomics.' 137 This approach has been used in a limited way to delineate RNAs bound to ARE-binding proteins in human cells.
Coordinated post-transcriptional regulation in differentiation
Cellular differentiation involves dramatic changes in gene expression. Several directed studies have shown that transcripts coding for proteins that regulate differentiation are stabilized together. For instance, muscle differentiation is dependent on the transcription factors MyoD and myogenin, and cell cycle exit of myocytes requires the p21 protein. HuR coordinately stabilizes messages for myogenin, MyoD and p21 during the myoblast to myocyte transition of C2C12 cells. 47, 138 Artificial knockdown of HuR prevents myocyte differentiation of C2C12 myoblasts; 138 however, it should be noted that knockout mouse results indicate that the ARE-binding protein NF90 plays a major role in stabilizing muscle-specific transcripts. 92 In neurons, stabilization of transcripts such as p21 and GAP-43 by Hu proteins is linked to neuronal differentiation, neurite outgrowth and spatial learning. 48, 139, 140 Hu protein stabilization of the p21 transcript in muscle and in neurons may control when differentiating cells stop proliferating. Acetylcholinesterase expression in both muscle and neurons is also controlled by Hu proteins. 141 Changes in Hu binding may be pertinent in myeloid differentiation as well -our laboratory has characterized changes in HuR binding activity in differentiating myeloid progenitor cells (Steinman, paper in preparation). HuR subcellular distribution has been shown to differ in differentiationmRNA stability control RA Steinman responsive compared with differentiation-resistant myeloid cells. 142 If cellular differentiation entails the stabilization of multiple transcripts by HuR, does it also involve a reduction in the activity of transcript destabilizing proteins? A handful of papers suggest that it does. A study by Gherzi's group showed that KSRP destabilized differentiation-related transcripts in myoblasts, and that differentiation stimuli inhibited KSRP function (Figure 3) . The stabilization of muscle-specific RNAs involved p38-induced phosphorylation of KSRP that decreased KSRP binding to ARE targets.
143 AUF1-mediated transcript destabilization may also change during differentiation. Loflin et al. 129 demonstrated that AUF1 was inhibited from destabilizing exogenous ARE-containing transcripts during hemin-induced erythroid differentiation of K562 erythroleukemic cells. Whether AUF1 destabilizes multiple endogenous transcripts in the undifferentiated state and whether loss of AUF1 degradation is necessary for erythroid differentiation has not been examined, however. We have noted a shift in cytoplasmic isoforms of AUF1 during granulopoiesis (Steinman, unpublished); it is conceivable that the differentiation trajectory of multiple hematopoietic lineages is impacted by shifts in binding by RNA destabilizing proteins.
Transcriptome targeting by ARE-binding proteins
The ability of ARE-binding proteins such as HuR and AUF1 to control turnover of key transcripts in differentiation raises the prospect that the functional architecture of the transcriptome could be rearranged by shifts in the population of stable transcripts. There are a few studies that have systematically analyzed the pool of transcripts bound by ARE-binding proteins.
Systemic analyses of HuR or HuB-bound mRNAs have been conducted by immunoprecipitation of HuR (HuB) from lysed cells followed by microarray analysis of associated mRNAs. 36, 51, 76, 144 These studies have shown that this is a robust technique and have highlighted the association of HuR with polysome-bound transcripts, indicating that the stabilized transcripts are sorted to the translational apparatus.
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AUF1 bound transcripts have been identified using a similar methodology.
These studies highlight the feasibility of global characterization of mRNA-protein interactions under different conditions, including differentiation or oncoprotein activation. With the exception of studies in neurons, 144, 145 this has not yet been done. Future studies will need to couple global profiles of mRNA-protein interactions with kinetic microarrays that measure the turnover of those mRNAs. Such an approach could uncover compelling details about how normal or malignant hematopoiesis depends on specific mediators of mRNA turnover and their network of targets.
Signaling pathways and mRNA turnover control
Because mRNA decay is highly responsive to environmental cues, many signaling pathways that mediate transcriptional responses to extracellular signals also regulate mRNA turnover rates. Transcript stability is controlled by kinases and other mediators characteristic of cytokine signal transduction pathways, including PKC, [146] [147] [148] [149] [150] PKB, 151 MAPK/Erk, 45 PI-3-kinase, 128, 152 Src-family kinases, 153 p38 MAPK (reviewed in Dean et al. 154 and Kotlyarov and Gaestel 155 ), mixed lineage kinase, 130 JNK kinases, 156, 157 and phosphatases such as calcineurin 127 and PP2A. 158 Several of these signaling intermediaries, particularly p38 and ERK have been shown to be important in stabilizing inflammatory transcripts downstream of LPS or IL-1. The example below relates how phosphorylation cascades can lead to stabilization of TNFa in myeloid cells.
Kinases have been shown to upregulate transcript stability by phosphorylating the destabilizing proteins TTP or KSRP. In myeloid cells, TNFa is stabilized when inflammatory stimuli Figure 3 Example of shifts in ARE-binding proteins leading to upregulation of differentiation-related genes in muscle cells. Exposure of C2C12 myoblasts to differentiation medium (lightning bolt) caused p38-dependent phosphorylation and dissociation of the destabilizing protein KSRP from transcripts enabling binding of the stabilizing protein HuR. Adapted with permission from Briata et al. 143 mRNA stability control RA Steinman activate p38 MAPK that in turn activates MAPK-activated protein kinase 2 (MK2). This leads to phosphorylation of TTP at serines 52 and 178, creating a docking site for 14-3-3 binding to TTP. 159, 160 This step, which is augmented by Erk signaling, 161 is associated with cytoplasmic accumulation and stabilization of the TTP complex. The destabilizing activity of TTP is coincidently suppressed. The mechanism for this has been controversial, 162 with some 163 but not all 158 studies showing that MK2 phosphorylated TTP had decreased affinity for target AREs. The association of 14-3-3 appears to prevent recruitment of TTP complexes to the stress granules where transcripts are sorted for degradation. [162] [163] [164] Eventually, the phosphatase PP2A binds to and dephosphorylates TTP, facilitating resumption of TTPmediated transcript decay. 158 A similar mechanism may link other kinases to downregulation of RNA destabilizing activity. Gherzi's laboratory has demonstrated that AKT phosphorylates KSRP on serine 193, creating a docking site for 14-3-3. 83 KSRP consequently loses its mRNA-destabilizing function because the KSRP/14-3-3 complex is unable to associate with the exosome. Similarly, protein kinase B phosphorylates BRF1 at serines 92 and 203 resulting in 14-3-3 binding and loss of mRNA decaying activity. 151 In contrast, 14-3-3 binding to the p37AUF1 has been reported to enhance degradation of AUF1 target transcripts. 121 The stabilizing protein HuR has been shown to accumulate in the cytoplasm in response to MK2 165 or AMPK. 68 This coincides with stabilization of ARE-containing transcripts. It would be interesting if these signaling pathways phosphorylated HuR to create 14-3-3 binding sites, as in the case of destabilizing RNABPs. This has not been described. Another way in which signaling kinases could relocalize HuR is by acting on pp32 or APRIL, two HuR ligands that facilitate its cytoplasmic relocalization. 166 Details of the signaling pathways that enable RNABPs to regulate transcript turnover are important because they can shed light on how hematopoietic cytokines can act at this posttranscriptional level. Nonetheless, surprisingly little is known about the downstream pathways through which cytokine receptors control mRNA stability, or about the RNABPs that are activated or altered in this process. It is notable that RNABPs can amplify the impact of incoming signals by simultaneously affecting many of the ARE-containing transcripts in the cell. Through such a mechanism, hematopoietic growth and differentiation factors have the potential to dramatically alter cellular phenotypes.
mRNA stability and cancer
Aberrant regulation of mRNA turnover has been implicated in malignancy. In several instances dysregulated mRNA turnover has been shown to arise from loss of destabilizing AU-rich sequences in the 3 0 -UTR or from increased binding of stabilizing factors to the ARE sequence. Deletion of the ARE-containing portion of the 3 0 -UTR coding for the c-fos transcription factor stabilizes the mRNA leading to c-fos overexpression and cellular transformation. 167 Similarly, c-myc is stabilized and overexpressed in T cell leukemia and in myeloma cells in which the ARE is deleted, 168, 169 although the physiologic role of the 3 0 -UTR in myc mRNA stability has been controversial [170] [171] Overexpression of cyclins have been associated with poor outcomes in cancer, including leukemias. [172] [173] [174] [175] In a subset of mantle cell lymphomas and in t(11q13) leukemias, cyclin D1 mRNA is stabilized in association with loss of the ARE element owing to DNA rearrangement. 176 A similar observation was made in a patient with chronic lymphocytic leukemia. 177 Cox-2 is a negative prognostic factor in colon, ovarian and gastric cancer; 178-180 overexpression of Cox-2 has been linked to increased Cox-2 mRNA stability. 85, 181 Other mechanisms of indirect interference with mRNA degradation may occur in cancers. The antiapoptotic gene, Bcl-2, is overexpressed in many cancers. Bcl-2 transcript contains an ARE and is rapidly degraded during apoptosis upon binding by the AUF1 protein (see below). 182 It has been reported that CDIR, a noncoding RNA overexpressed in lung cancer, 183 sequesters AUF1 away from Bcl-2 transcript, supporting Bcl-2 overexpression. 184 A recently identified oncoprotein, CaSM, appears to act by enhancing the stability of mRNAs including cyclin B1 by inhibiting 5 0 to 3 0 mRNA degradation. 185 Given their central role in coordinating mRNA turnover, it is not surprising that aberrant expression of ARE-binding proteins occurs in malignancy. Both AUF1 and Hur are overexpressed in the cytoplasm of aggressive lung cancers. 186 Cytoplasmic expression of HuR is associated with poor clinical outcomes in ovarian and breast cancers, 88, 187 and is accompanied by stabilization of Cox-2 message leading to Cox-2 overexpression. 88, 188, 189 Other Hur targets, such as cyclins A and B1, c-fos and angiogenic factors 33, 71, 190 may also contribute to the oncogenicity of dysregulated HuR. Gorospe's laboratory demonstrated that artificial upregulation of HuR in colon cancer cells increased tumorigenicity in vivo, whereas HuR downmodulation via RNA interference decreased tumorigenicity of colon cancer xenografts. 191 The p37 isoform of AUF1 was found to have oncogenic activity when overexpressed in transgenic mice. 123 Analysis of the tumors was most consistent with poorly differentiated sarcomas. p37AUF1 was prominently expressed in tumor tissue, and cyclin D1 mRNA and protein was overexpressed 20-50-fold compared with normal or nontransgenic tissues. Cyclin D1 contains a class I ARE; as noted above several transcripts in this category exhibited heightened expression in the p37 transgenic mice.
The examples cited above demonstrate a linkage between abnormal posttranscriptional control of key transcripts and cancer. Relatively few investigations have studied derangement of mRNA turnover control in hematopoietic malignancies. However, given the central role in hematopoiesis of AREcontaining transcripts such as cytokines, bcl-2, catenins, c-myc and other early response genes, the paradigms established in solid cancers are likely to apply to leukemias and lymphomas.
Alterations in RNA Stability in Leukemia
Because proliferative cytokines such as IL-3 are regulated via ARE-mediated turnover, it is possible that heightened stabilization of hematopoietic growth factors could support leukemia progression through an autocrine mechanism. High expression of the IL-3 receptor has been noted in leukemic blasts 192, 193 and correlates with enhanced cycling of blasts and poor patient oucomes. 194 IL-3 is frequently expressed by leukemic myeloblasts 195, 196 and can promote clonogenicity of primary blasts. 197 Disruption of the IL-3 ARE has been shown to enhance autocrine IL-3 production and tumorigenicity in nude mice. 198 Conceivably, leukemic blast proliferation could in some cases be decreased by enhancing the turnover of IL-3 transcripts.
Stoecklin et al. 199 tested this in a v-H-ras mast cell tumor model characterized by abnormally stable IL-3 expression. By transfecting cells with the ARE-destabilizing protein TTP, they enhanced IL-3 degradation, blocked autocrine cell growth and delayed tumor growth in a syngeneic mouse model. This mRNA stability control RA Steinman approach of ARE-directed tumor suppression could in theory be directed not only to autocrine growth factors but also to downstream effector genes bearing ARE sequences. Hematopoietic cytokines are regulators as well as targets of mRNA decay. Matsui et al. 200 have recently demonstrated that Bim-mediated apoptosis is prevented in an IL-3-dependent cell line by IL-3-mediated decay of Bim transcript.
Leukemic oncoproteins have been shown to appropriate downstream signaling pathways utilized by proliferative or antiapoptotic cytokines. Given the involvement of signaling kinases in controlling ARE-binding proteins and transcript turnover, it is likely that aberrant mRNA decay is a central feature of dysregulated signal transduction in leukemia (Figure 4 ).
Two recent reports implicate abnormal activation of RNABPs in leukemia
Overexpression of Bcl-2 at the mRNA and protein level often occurs in B cell chronic lymphocytic leukemia. 201 Bcl-2 has been shown to contribute to the resistance of B-CLL cells to apoptosis (reviewed by Danilov et al. 202 ) and inhibition of Bcl-2 function leads to apoptosis of B-CLL cells ex vivo. 203 The accumulation of Bcl-2 does not result from chromosomal rearrangement. Otake et al. 204 examined the expression of the RNA-binding protein nucleolin in B cells from 17 patients with B-CLL. Nucleolin had been demonstrated to stabilize bcl-2 mRNA in HL-60 cells, 94 moreover, induction of HL-60 apoptosis by retinoids had been shown to involve bcl-2 mRNA destabilization and nucleolin downregulation. 205 In B-CLL cells, nucleolin was found to accumulate in the cytoplasm, wherein it was primarily nuclear in normal CD19 þ B cells. The stability of Bcl-2 was correspondingly enhanced by cytoplasmic extracts from B-CLL cells in in vitro degradation assays. 204 This study implicates nucleolin binding to the ARE of Bcl-2 mRNA in B-CLL chemoresistance, although it remains to be seen whether forced nuclear sequestration or knockdown of nucleolin enhances B-CLL chemosensitivity. Several other mRNA targets of nucleolin have been identified. 97, 206, 207 It will be interesting to see whether the repetoire of nucleolin-bound mRNAs in B-CLL cells is enriched for transcripts coding for antiapoptotic proteins.
Leukemic oncoproteins may directly alter the activity of proteins controlling RNA turnover. This is supported by an investigation that links the NPM-ALK fusion protein found in anaplastic large cell lymphoma to increased stability of proliferative transcripts targeted by AUF1. 208 Fawal et al.
208
noted that transforming ALK fusion proteins bound to AUF1 in the cytoplasm. This led to increased tyrosine phosphorylation of p45AUF1, which along with p42AUF1 predominated in the NPM-ALK complex. A coincident increase in the half-life of c-myc and cyclin transcripts was observed. Conceivably, phosphorylation of AUF1 decreased its binding to ARE's in these transcripts and resultant mRNA turnover. Future experiments will be needed to establish the mechanism of transcript stabilization in these cells as well as the functional consequences of AUF1 phosphorylation. It remains to be established whether AUF1 or other AREBPs are commonly altered at the posttranscriptional level by leukemic oncoproteins. Such a model is supported by the evidence that RNABPs are responsive to signal transduction pathways that are frequently activated in leukemias.
Concluding remarks
Will decay have its day? Even though studies to date have focused on relatively few proteins that control mRNA turnover, they have offered a tantalizing glimpse of the dramatic impact of mRNA turnover on the transcriptional landscape of the cell. Still, several questions stand out. What transcript half-lives are controlled by what cytokines? What sequence or structural motifs mark transcripts for synchronous stabilization or decay? Does a given binding protein control different sets of transcripts in response to different stimuli? What is the impact of posttranslational modifications of RNABPs on their activity, their recruitment into multi-protein complexes or on their choice of transcriptional targets? By delineating pathways from cytokines to mRNA turnover, it will be easier to predict how those pathways could be hijacked in leukemias. Leukemic oncoproteins could target the RNABPs that control the turnover of subsets of transcripts, thereby reordering the genetic architecture of cells to promote survival and replication and to block differentiation. This paradigm, if validated, has significant implications for therapeutics. The restoration of normal functioning by a key RNABP could comprise an efficient way to normalize expression of multiple transcripts. Therapies to achieve this could target posttranscriptional alterations in RNABPs, subcellular localization of RNABPs, or the structure and accessibility of RNA motifs bound by these proteins. 
